Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ⅱ Study to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula

NCT05677672 is registered in ClinicalTrials.gov with Jiangsu Topcel-KH Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05677672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ⅱ Study to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula
Lead sponsor
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 30, 2022
Completion date
December 30, 2023
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complex perianal fistulas